{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:56:33Z","timestamp":1783446993839,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.parkreldis.2018.06.034","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T09:14:53Z","timestamp":1530522893000},"page":"93-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8735-0796","authenticated-orcid":false,"given":"Adam","family":"Margolius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cubillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-1644","authenticated-orcid":false,"given":"Tanya","family":"Simuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.06.034_bib1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's and Parkinson's disease \u00a9","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic - a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib4","series-title":"Adam and Victor's Principles of Neurology","author":"Ropper","year":"2014"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib5","series-title":"Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease","author":"Micheel","year":"2010"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0277-9536(98)00009-4","article-title":"The world health organization quality of life assessment (whoqol): DEVELOPMENT and general psychometric properties* the whoqol group","volume":"46","author":"WHOQOL Group","year":"1998","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","article-title":"Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes","volume":"273","author":"Wilson","year":"1995","journal-title":"Jama"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2010.08.012","article-title":"Determinants of health-related quality of life in Parkinson's disease: a systematic review","volume":"17","author":"Soh","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.parkreldis.2013.10.004","article-title":"Mobility, mood and site of care impact health related quality of life in Parkinson's disease","volume":"20","author":"Nutt","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.25664","article-title":"Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms","volume":"29","author":"Duncan","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.parkreldis.2010.06.005","article-title":"Piloting the NPF data-driven quality improvement initiative","volume":"16","author":"Okun","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019 s disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib14","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/PL00007730","article-title":"PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ageing\/30.4.299","article-title":"Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire","volume":"30","author":"Peto","year":"2001","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib16","doi-asserted-by":"crossref","DOI":"10.1159\/000455863","article-title":"Changes in quality of life in Parkinson's disease: how large must they Be to Be relevant?","author":"Horv\u00e1th","year":"2017","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.parkreldis.2006.07.009","article-title":"Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study","volume":"13","author":"Reuther","year":"2007","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","article-title":"A S. Kapadia, Functional decline in Parkinson disease","volume":"58","author":"Jankovic","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.parkreldis.2014.09.008","article-title":"Back to the basics: regular exercise matters in Parkinson's disease: results from the National Parkinson Foundation QII registry study","volume":"20","author":"Oguh","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JPD-160912","article-title":"Regular exercise, quality of life, and mobility in Parkinson's disease: a longitudinal analysis of national Parkinson foundation quality improvement initiative data","volume":"7","author":"Rafferty","year":"2017","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000314963","article-title":"Properties of the \u201ctimed up and Go\u201d test: more than meets the eye","volume":"57","author":"Herman","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3233\/JPD-140382","article-title":"Recognition and treatment of depressive symptoms in Parkinson's disease: the NPF dataset","volume":"4","author":"Bega","year":"2014","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.parkreldis.2018.06.034_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1590\/S0004-282X2009000200006","article-title":"Depressive symptoms and perception of quality of life in Parkinson's disease","volume":"67","author":"Scalzo","year":"2009","journal-title":"Arq. Neuropsiquiatr"},{"key":"10.1016\/j.parkreldis.2018.06.034_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.69.1.67","article-title":"The EQ-5D\u2013a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease","volume":"69","author":"Schrag","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201830302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201830302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T22:06:25Z","timestamp":1604527585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201830302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":24,"alternative-id":["S135380201830302X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.034","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}